Califf Supports Combo Products Pathway At Confirmation Hearing

FDA's concepts for a new pathway could be ready for congressional scrutiny within a year, Deputy Commission Robert Califf said during his confirmation hearing before the Senate HELP Committee. Most committee members expressed support for Califf's nomination to lead FDA, although he fielded some questions on his ties to industry.

More from Regulation

More from Policy & Regulation